Richard Hawkins

Richard J.
Hawkins was the founder of Pharmaco, established in 1982, serving as Chairman, President & Chief Executive Officer until 2000.
Founder of id2, Inc, established in 1992, holding the position of President & Chief Executive Officer since 1992.
Founder of Sensus Drug Development Corp., established in 1992, serving as Chairman from 1992 to 2001.
Founder of Diosynth RTP, Inc., established in 1994, serving as Director from 1994 to 2000.
Founder of Covance Biotechnology Services, Inc., established in 1995, serving as Director.
Founder of LabNow, Inc., established in 2003, serving as Chairman, President & Chief Executive Officer from 2003 to 2009.
Founder of Lumos Pharma Sub, Inc., established in 2010, serving as President, Chief Executive Officer & Director from 2010 to 2020.
Founder of Entvantage Diagnostics, Inc., established in 2014, serving as Chairman since 2014.
Current positions include Chairman at Plus Therapeutics, Inc. since 2018, Independent Director at Savara, Inc. since 2010, Director at Cytori Therapeutics, Inc., and Operating Partner at Havencrest Capital Management LLC.
Former positions include Chief Executive Officer & Director at NewLink Genetics Corp.
in 2020, Chairman & Chief Executive Officer at Lumos Pharma, Inc. from 2021 to 2024, Chairman at LoopOne, Inc., Independent Director at SciClone Pharmaceuticals LLC from 2004 to 2017, Director at Aravas, Inc., Director at Synexus Compass, Inc., Director at Entvantage Diagnostic Associates LLC, Board member at Aravas, Inc., and General Partner at Dominion Ventures, Inc.Education includes an undergraduate degree from The Ohio University, conferred in 1972.